Literature DB >> 19150677

Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus.

Lone Graff Stensballe1, Henrik Ravn, Kim Kristensen, Tiffany Meakins, Peter Aaby, Eric A F Simoes.   

Abstract

This study used 459 prospectively sampled cord blood samples to examine the association between maternally derived respiratory syncytial virus (RSV)-neutralizing antibodies and the RSV hospitalization season in Denmark. We found a clear temporal association and suggest that RSV-neutralizing antibody level plays a role in the RSV seasonal pattern.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19150677     DOI： 10.1016/j.jpeds.2008.07.053

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  37 in total

1.  Evaluation of IgG Antibodies Against Respiratory Syncytial Virus (RSV), and Associated Risk Factors for Severe Respiratory Tract Infections in Pre-School Children in North-Central, Nigeria.

Authors:  Adedayo Faneye; Babatunde O Motayo; Adeyinka Adesanmi; Bernard Onoja
Journal:  Afr J Infect Dis       Date:  2014

2.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

Review 3.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

4.  Airway T cells protect against RSV infection in the absence of antibody.

Authors:  E Kinnear; L Lambert; J U McDonald; H M Cheeseman; L J Caproni; J S Tregoning
Journal:  Mucosal Immunol       Date:  2017-05-24       Impact factor: 7.313

5.  Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.

Authors:  Bart G Jones; Robert E Sealy; Rajeev Rudraraju; Vicki L Traina-Dorge; Brad Finneyfrock; Anthony Cook; Toru Takimoto; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2011-11-23       Impact factor: 3.641

6.  Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines.

Authors:  Robert Sealy; Richard J Webby; Jeri C Crumpton; Julia L Hurwitz
Journal:  Int Immunol       Date:  2012-11-08       Impact factor: 4.823

7.  Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.

Authors:  Anurag Sharma; Rebecca Wendland; Biin Sung; Wenzhu Wu; Thomas Grunwald; Stefan Worgall
Journal:  Vaccine       Date:  2014-08-26       Impact factor: 3.641

8.  Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.

Authors:  Youran Noh; Byoung-Shik Shim; In Su Cheon; Semi Rho; Hee Joo Kim; Youngjoo Choi; Chang-Yuil Kang; Jun Chang; Man Ki Song; Jae-Ouk Kim
Journal:  Viral Immunol       Date:  2013-07-19       Impact factor: 2.257

9.  Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Authors:  Bart G Jones; Robert E Sealy; Sherri L Surman; Allen Portner; Charles J Russell; Karen S Slobod; Philip R Dormitzer; John DeVincenzo; Julia L Hurwitz
Journal:  Vaccine       Date:  2014-04-14       Impact factor: 3.641

10.  The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.

Authors:  Rachel Ochola; Charles Sande; Gregory Fegan; Paul D Scott; Graham F Medley; Patricia A Cane; D James Nokes
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.